|
1 Company |
|
3 Products |
|
3 Products |
|
1 Mechanism of Action |
|
0 Trials |
|
25 News |
|
- | Trial completion date: Cognitive Behavioral Therapy for Paranoia in Schizophrenia (clinicaltrials.gov) - Dec 4, 2018
P=N/A, N=24, Completed, Sponsor: Weill Medical College of Cornell University
Trial completion date: Dec 2012 --> Jun 2017
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial primary completion date: Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk (clinicaltrials.gov) - Dec 4, 2018
P=N/A, N=13, Completed, Sponsor: Weill Medical College of Cornell University
Trial completion date: Dec 2012 --> Jun 2017 Recruiting --> Completed | N=24 --> 13 | Trial primary completion date: Dec 2017 --> Sep 2018
- | Trial primary completion date: Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk (clinicaltrials.gov) - Nov 22, 2017
P=N/A, N=24, Recruiting, Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed | N=24 --> 13 | Trial primary completion date: Dec 2017 --> Sep 2018 Trial primary completion date: Dec 2016 --> Dec 2017
- | Trial completion, Enrollment change: Computerised Interventions for Thinking and Anxiety in Delusions (CITADEL) Trial (clinicaltrials.gov) - Mar 20, 2017
P=N/A, N=25, Completed, Sponsor: King's College London
Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Completed | N=34 --> 25
- Trial completion: PSYCHOCOKE: Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers (clinicaltrials.gov) - Dec 8, 2016
P=N/A, N=417, Completed, Sponsor: Assistance Publique - H
Recruiting --> Completed | N=34 --> 25 Recruiting --> Completed
- Trial completion, Trial primary completion date: Lifestyle Intervention for Diabetes and Weight Management in Psychosis (clinicaltrials.gov) - Jun 18, 2016
P=N/A, N=120, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> May 2015
- Enrollment change: Computerised Interventions for Thinking and Anxiety in Delusions (CITADEL) Trial (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=34, Recruiting, Sponsor: King's College London
Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> May 2015 N=46 --> 34
- Trial primary completion date: Computerised Interventions for Thinking and Anxiety in Delusions (CITADEL) Trial (clinicaltrials.gov) - Oct 6, 2015
P=N/A, N=46, Recruiting, Sponsor: King's College London
N=46 --> 34 Trial primary completion date: Sep 2015 --> Sep 2016
- ||| Trial completion: Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia (clinicaltrials.gov) - Jun 11, 2015
P1, N=68, Completed, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Sep 2015 --> Sep 2016 Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: MCT: Metacognitive Training in Schizophrenia (clinicaltrials.gov) - Mar 3, 2015
P=N/A, N=60, Completed, Sponsor: Universit
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: May 2012 --> Dec 2013
- Trial primary completion date: PSYCHOCOKE: Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers (clinicaltrials.gov) - Dec 17, 2014
P=N/A, N=400, Recruiting, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed | Trial primary completion date: May 2012 --> Dec 2013 Trial primary completion date: Oct 2014 --> Nov 2016
- Enrollment closed, Trial primary completion date: Lifestyle Intervention for Diabetes and Weight Management in Psychosis (clinicaltrials.gov) - Nov 7, 2014
P=N/A, N=120, Active, not recruiting, Sponsor: Centre for Addiction and Mental Health
Trial primary completion date: Oct 2014 --> Nov 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2015
- || Enrollment closed: Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia (clinicaltrials.gov) - Oct 17, 2014
P1, N=80, Active, not recruiting, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2015 Recruiting --> Active, not recruiting
- Enrollment open, Enrollment change: Computerised Interventions for Thinking and Anxiety in Delusions (CITADEL) Trial (clinicaltrials.gov) - Aug 12, 2014
P=N/A, N=46, Recruiting, Sponsor: King's College London
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | N=72 --> 46
- Trial initiation date: Computerised Interventions for Thinking and Anxiety in Delusions (CITADEL) Trial (clinicaltrials.gov) - Dec 12, 2013
P=N/A, N=72, Not yet recruiting, Sponsor: King's College London
Not yet recruiting --> Recruiting | N=72 --> 46 Initiation date: Sep 2013 --> Jan 2014
- | methamphetamine / Generic mfg., haloperidol / Generic mfg., quetiapine / Generic mfg.
New P4 trial: Therapeutic Effect of Quetiapine on Methamphetamine-Induced Psychosis (clinicaltrials.gov) - Sep 9, 2013
P4, N=80, Completed, Sponsor: Chulalongkorn University
- Enrollment open: Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk (clinicaltrials.gov) - Aug 12, 2013
P=N/A, N=24, Recruiting, Sponsor: Weill Medical College of Cornell University
Initiation date: Sep 2013 --> Jan 2014 Not yet recruiting --> Recruiting
- Clinical: Lifestyle Intervention for Diabetes and Weight Management in Psychosis (clinicaltrials.gov) - Apr 9, 2013
P=N/A, N=120, Recruiting, Sponsor: Centre for Addiction and Mental Health
- Enrollment change: Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia (clinicaltrials.gov) - Mar 10, 2013
P1, N=80, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Not yet recruiting --> Recruiting N=54 --> 80
- Enrollment change: Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy (clinicaltrials.gov) - Dec 11, 2012
P=N/A, N=34, Completed, Sponsor: New York State Psychiatric Institute
N=54 --> 80 N=72 --> 34
- Trial completion: Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy (clinicaltrials.gov) - Dec 11, 2012
P=N/A, N=34, Completed, Sponsor: New York State Psychiatric Institute
N=72 --> 34 Recruiting --> Completed
- Trial completion: Prevention of Weight Gain in Early Psychoses (clinicaltrials.gov) - Dec 3, 2012
P=N/A, N=70, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed Recruiting --> Completed
- Enrollment closed: Cognitive Behavioral Therapy for Paranoia in Schizophrenia (clinicaltrials.gov) - Oct 9, 2012
P=N/A, N=24, Active, not recruiting, Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed Not yet recruiting --> Active, not recruiting
- Enrollment open: PSYCHOCOKE: Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers (clinicaltrials.gov) - Jun 13, 2012
P=N/A, N=400, Recruiting, Sponsor: Assistance Publique - H
Not yet recruiting --> Active, not recruiting Not yet recruiting --> Recruiting